This approach not only confirmed well-known aspects of liver metabolism but also uncovered unexpected activities such as de novo creatine synthesis and branched-chain amino acid transamination, highlighting significant differences from rodent models.
The study represents a significant advancement in furthering our understanding of human liver metabolism, offering critical insights into the pathology of metabolic diseases. This has promising implications for target discovery, toxicity assessment, and targeted therapeutic development.
To learn more, read the full paper and findings.